Randomized Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide (TC) (ADVANCE) - Regional Cancer Care Associates LLC

Clinical Trials

Randomized Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide (TC) (ADVANCE)

Type of Cancer
Breast Oncology
Locations
Bethesda
Sponsor
Spectrum Pharmaceuticals
Protocol Number
SPI-GCF-301
Cancer Diagnosis
To Learn More Call
201-510-0910